Self-sufficient catalytic system of human cytochrome P450 4A11 and NADPH-P450 reductase

Biomolecules and Therapeutics

Volumn 17, Issue 2, 2009, Pages 156-161

  Han, Songhee ^a   Eun, Chang Yong ^a   Han, Jung Soo ^a   Chun, Young Jin ^b   Kim, Dong Hyun ^c   Yun, Chul Ho ^c   Kim, Donghak ^a  

^a Konkuk University   (South Korea)

^b Chung Ang University   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

Arachidonic acid; Bicistronic expression; Lauric acid; P450 4A11

Indexed keywords

CYTOCHROME P450 4A11; LAURIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL CELL; CATALYSIS; CISTRON; CULTURE MEDIUM; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN; NONHUMAN; OMEGA HYDROXYLAURIC ACID; OXIDATION; PROTEIN EXPRESSION; REACTION ANALYSIS;

ESCHERICHIA COLI;

EID: 69549109918     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2009.17.2.156     Document Type: Article

References (27)

1. Baer, B. R. and Rettie, A. E. (2006). CYP4B1: an enigmatic P450 at the interface between xenobiotic and endobiotic metabolism. Drug Metab. Rev. 38, 451-476.
2. CaJacob, C. A., Chan, W. K., Shephard, E. and Ortiz de Montellano, P. R. (1988). The catalytic site of rat hepatic lauric acid omega-hydroxylase. Protein versus prosthetic heme alkylation in the omega-hydroxylation of acetylenic fatty acids. J. Biol. Chem. 263, 18640-18649.
3. Capdevila, J. H., Falck, J. R. and Harris, R. C. (2000). Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 41, 163-181. (Pubitemid 30117856)
4. Chae, A. R., Shim, J. H. and Chun, Y. J. (2008). Mechanism of inhibition of human cytochrome P450 IAI and IBI by piceatannol. Biomol. Ther. 16, 336-342.
5. Clark, B. J. and Waterman, M. R. (1992). Functional expression of bovine 17 alpha-hydroxylase in COS 1 cells is dependent upon the presence of an amino-terminal signal anchor sequence. J. Biol. Chem. 267, 24568-24574.
6. Dong, M. S., Bell, L. C., Guo, Z., Phillips, D. R., Blair, I. A. and Guengerich, F. P. (1996). Identification of retained N-formylmethionine in bacterial recombinant mammalian cytochrome P450 proteins with the N-terminal sequence MALLLAVFL...: roles of residues 3-5 in retention and membrane topology. Biochemistry 35, 10031-10040. (Pubitemid 26269918)
7. Gillam, E. M., Guo, Z., Martin, M. V., Jenkins, C. M. and Guengerich, F. P. (1995). Expression of cytochrome P450 2D6 in Escherichia coli, purification, and spectral and catalytic characterization. Arch. Biochem. Biophys. 319, 540-550.
8. Guengerich, F. P. (1993). Cytochrome P450 enzymes. American Scientist 81, 440-447.
9. Gungerich, F. P. (2001). Analysis and characterization of enzymes. In Principles and Methods of Toxicology, 4th ed. (A. W. Hayes, Ed.), pp 1625-1687. Taylor & Francis, Philadephila.
10. Guengerich, F. P. (2002). Cytochrome P450 enzymes in the generation of commercial products. Nature Rev. Drug Discov. 1, 359-366. (Pubitemid 37361465)
11. Guengerich, F. P. (2008). Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol. 21, 70-83.
12. Guengerich, F. P., Gillam, E. M. J. and Shimada, T. (1996). New applications of bacterial systems to problems in toxicology. CRC Critical Reviews in Toxicology 26, 551-583.
13. Hoch, U., Falck, J. R. and Ortiz de Montellano, P. R. (2000). Molecular basis for the omega-regiospecificity of the CYP4A2 and CYP4A3 fatty acid hydroxylases. J. Biol. Chem. 275, 26952-26958.
14. Hoch, U. and Ortiz De Montellano, P. R. (2001). Covalently linked heme in cytochrome p4504a fatty acid hydroxylases. J. Biol. Chem. 276, 11339-11346.
15. Hoch, U., Zhang, Z., Kroetz, D. L. and Ortiz de Montellano, P. R. (2000). Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Arch. Biochem. Biophys. 373, 63-71.
16. Hsu, M. H., Savas, U., Griffin, K. J. and Johnson, E. F. (2007). Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation. Drug Metab. Rev. 39, 515-538. (Pubitemid 47355735)
17. Imig, J. D. and Navar, L. G. (1996). Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways. Am. J. Physiol. 271, F87-F93. (Pubitemid 26298880)
18. Kim, D., Cryle, M. J., De Voss, J. J. and Ortiz de Montellano, P. R. (2007). Functional expression and characterization of cytochrome P450 52A21 from Candida albicans. Arch. Biochem. Biophys. 464, 213-220.
19. Kim, D. and Guengerich, F. P. (2004). Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation. Biochemistry 43, 981-988. (Pubitemid 38141496)
20. LeBrun, L. A., Hoch, U. and Ortiz de Montellano, P. R. (2002). Autocatalytic mechanism and consequences of covalent heme attachment in the cytochrome P4504A family. J. Biol. Chem. 277, 12755-12761.
21. Ma, Y. H., Gebremedhin, D., Schwartzman, M. L., Falck, J. R., Clark, J. E., Masters, B. S., Harder, D. R. and Roman, R. J. (1993). 20- Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ. Res. 72, 126-136.
22. Murphy, T. M., Vu, H. and Nguyen, T. (1998). The superoxide synthases of rose cells. Plant Physiol. 117, 1301-1305
23. Ortiz de Montellano, P. R. (2005). In Cytochrome P450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano, P. R., Ed.) Plenum Press, New York.
24. Ortiz de Montellano, P. R. (2008). Mechanism and role of covalent heme binding in the CYP4 family of P450 enzymes and the mammalian peroxidases. Drug Metab. Rev. 40, 405-426.
25. Parikh, A., Gillam, E. M. J. and Guengerich, F. P. (1997). Drug metabolism by Escherichia coli expressing human cytochromes P450. Nature Biotechnol. 15, 784-788. (Pubitemid 27329483)
26. Stark, K. and Guengerich, F. P. (2007). Characterization of orphan human cytochromes P450. Drug Metab. Rev. 39, 627-637. (Pubitemid 47355742)
27. Zeldin, D. C. (2001). Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276, 36059-36062. (Pubitemid 37384204)